Although recent reports have confirmed an upstream promoter region of MDR1 containing seven consensus binding sites of LEF/TCF in neuroblastoma, colorectal cancer, and breast cancer26,31,32, this regulation has not been investigated in HCC. This evidence concerns the gene HNF4A and hepatocellular carcinoma.